Modulation of NF-κB activation by resveratrol in LPS treated human intestinal cells results in downregulation of PGE2 production and COX-2 expression

Toxicology in Vitro

Volumn 26, Issue 7, 2012, Pages 1122-1128

  Cianciulli, Antonia ^a   Calvello, Rosa ^a   Cavallo, Pasqua ^a   Dragone, Teresa ^a   Carofiglio, Vito ^a   Panaro, Maria Antonietta ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

COX 2; Intestinal cells; Lipopolysaccharide; NF B; PGE2; Resveratrol

Indexed keywords

CYCLOOXYGENASE 2; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROSTAGLANDIN E2; RESVERATROL; TRANSCRIPTION FACTOR RELA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; COX2 GENE; DRUG MECHANISM; DRUG SCREENING; ENZYME PHOSPHORYLATION; FATTY ACID SYNTHESIS; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; INTESTINE CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION;

ANTIOXIDANTS; CACO-2 CELLS; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; DOWN-REGULATION; ENTEROCYTES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIPOPOLYSACCHARIDES; NF-KAPPA B; STILBENES;

VITACEAE;

EID: 84866012639     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.06.015     Document Type: Article

References (33)

1. Agarwal S., Reddy G.V., Reddanna P. Eicosanoids in inflammation and cancer: the role of COX-2. Expert Rev. Clin. Immunol. 2009, 5:145-165. (PMID:20477063).
2. Araújo J.R., Gonçalves P., Martel F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr. Res. 2011, 31:77-87. (PMID:21419311).
3. Bhat K.P., Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Ann. NY Acad. Sci. 2002, 957:210-229. (PMID:12074974).
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254. (PMID:942051).
5. Callejas N.A., Casado M., Diaz-Guerra M.J., Bosca L., Martin-Sanz P. Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes. Hepatology 2001, 33:860-867. (PMID:11283850).
6. Campbell K.J., Perkins N.D. Regulation of NF-kappaB function. Biochem. Soc. Symp. 2006, 73:165-180. (PMID:16626297).
7. Eckmann L., Stenson W.F., Savidge T.C., Lowe D.C., Barrett K.E., Fierer J., Smith J.R., Kagnoff M.F. Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. J. Clin. Invest. 1997, 100:296-309. (PMID:9218506).
8. Goldberg D.M., Yan J., Soleas G.J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 2003, 36:79-87. (PMID:12554065).
9. Grishin A.V., Wang J., Potoka D.A., Hackam D.J., Upperman J.S., Boyle P., Zamora R., Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway. J. Immunol. 2006, 176:580-588. (PMID:16365453).
10. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220. (PMID:8985016).
11. Jobin C., Haskill S., Mayer L., Panja A., Sartor R.B. Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J. Immunol. 1997, 158:226-234. (PMID:8977194).
12. Kaldas M.I., Walle U.K., Walle T. Resveratrol transport and metabolism by human intestinal Caco-2 cells. J. Pharm. Pharmacol. 2003, 55:307-312. (PMID:12724035).
13. Kim H.J., Lee S.K., Kim M.H., Seo D.W., Min Y.I. Cyclooxygenase-2 mediates mucin secretion from epithelial cells of lipopolysaccharide treated canine gallbladder. Dig. Dis. Sci. 2003, 48:726-732. (PMID:12749290).
14. MacDonald T., Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005, 307:1920-1925. (PMID:15790845).
15. Maier-Salamon A., Hagenauer B., Wirth M., Gabor F., Szekeres T., Jäger W. Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites. Pharm. Res. 2006, 23:2107-2115. (PMID:16952002).
16. Martín A.R., Villegas I., La Casa C., de la Lastra C.A. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem. Pharmacol. 2004, 67:1399-1410. (PMID:15013856).
17. Martín A.R., Villegas I., Sánchez-Hidalgo M., de la Lastra C.A. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br. J. Pharmacol. 2006, 147:873-885. (PMID:16474422).
18. Panaro M.A., Carofiglio V., Acquafredda A., Cavallo P., Cianciulli A. Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells. Br. J. Nutr. 2012, 17:1-10. (PMID:22251620).
19. Pohl C., Hombach A., Kruis W. Chronic inflammatory bowel disease and cancer. Hepatogastroenterology 2000, 47:57-70. (PMID:10690586).
20. Rahman I., Biswas S.K., Kirkham P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol. 2006, 72:1439-1452. (PMID:16920072).
21. Romier B., Schneider Y.J., Larondelle Y., During A. Dietary polyphenols can modulate the intestinal inflammatory response. Nutr. Rev. 2009, 67:363-378. (PMID:19566597).
22. Rouzer C.A., Marnett L.J. Cyclooxygenases: structural and functional insights. J. Lipid Res. 2009, 50:29-34. (PMID:18952571).
23. Sánchez-Fidalgo S., Cárdeno A., Villegas I., Talero E., de la Lastra C.A. Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur. J. Pharmacol. 2010, 633:78-84. (PMID:20132809).
24. Sebai H., Sani M., Yacoubi M.T., Aouani E., Ghanem-Boughanmi N., Ben-Attia M. Resveratrol, a red wine polyphenol, attenuates lipopolysaccharide-induced oxidative stress in rat liver. Ecotoxicol. Environ. Saf. 2010, 5:1078-1083. (PMID:20089305).
25. Singh U.P., Singh N.P., Singh B., Hofseth L.J., Price R.L., Nagarkatti M., Nagarkatti P.S. Resveratrol (trans-3,5,4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis. J. Pharmacol. Exp. Ther. 2010, 332:829-839. (PMID:19940103).
26. Torres M.I., Rios A. Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. World J. Gastroenterol. 2008, 14:1972-1980. (PMID:9705326).
27. Tsai S.H., Lin-Shaiu S.Y., Lin J.K. Suppression of nitric oxide synthase and downregulation of the activation of NF kappaB in macrophages by resveratrol. Br. J. Pharmacol. 1999, 126:673-680. (PMID: 10188978).
28. Viatour P., Merville M.P., Bours V., Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 2005, 30:43-52. (PMID:15653325).
29. Wang D., Dubois R.N. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 2010, 29:81-88. (PMID:19946329).
30. Williams C.S., Mann M., DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999, 18:7908-7916. (PMID:19946329).
31. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434. (PMID:17653185).
32. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A., Mayo M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23:2369-2380. (PMID:15152190).
33. Zhang R., Li S. COX-2 as a novel target of CRF family peptides' participating in inflammation. Biochem. Biophys. Res. Commun. 2009, 382:483-485. (PMID:19292978).